Poorer prognosis in Taiwanese female ever smokers with stage IV lung adenocarcinoma who were readministered a tyrosine kinase inhibitor

BACKGROUND: Readministering a second epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) in patients with lung adenocarcinoma with acquired resistance to an initial EGFR TKI is a common treatment strategy. However, the prognostic factors for the second EGFR TKI are still uncertai...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Yang, Chih-Jen, Tsai, Ming-Ju, Hung, Jen-Yu, Tsai, Ying-Ming, Lee, Jui-Ying, Chou, Shah-Hwa, Liu, Ta-Chih, Shen, Mei-Chiou, Huang, Ming-Shyan, Chong, Inn-Wen
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2016
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4801161/
https://ncbi.nlm.nih.gov/pubmed/27042119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S100169
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados